[
  {
    "ts": "2025-11-13T13:00:00+00:00",
    "headline": "Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025",
    "summary": "Viatris Inc. (Nasdaq: VTRS) today announced that it has been recognized as one of the Fortune World's Best Workplaces™ in 2025. The list of 25 global leaders was selected from organizations that participated in Great Place To Work's employee survey process, with over 9 million responses representing more than 25 million employees worldwide. To be considered for the list, companies must have 5,000 or more global employees, be identified as outstanding global employers with recognition on at least",
    "url": "https://finance.yahoo.com/news/viatris-recognized-one-fortune-worlds-130000796.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e7c07a2b-2715-3413-a4e0-de05eefdd4a6",
      "content": {
        "id": "e7c07a2b-2715-3413-a4e0-de05eefdd4a6",
        "contentType": "STORY",
        "title": "Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025",
        "description": "",
        "summary": "Viatris Inc. (Nasdaq: VTRS) today announced that it has been recognized as one of the Fortune World's Best Workplaces™ in 2025. The list of 25 global leaders was selected from organizations that participated in Great Place To Work's employee survey process, with over 9 million responses representing more than 25 million employees worldwide. To be considered for the list, companies must have 5,000 or more global employees, be identified as outstanding global employers with recognition on at least",
        "pubDate": "2025-11-13T13:00:00Z",
        "displayTime": "2025-11-13T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b",
          "originalWidth": 400,
          "originalHeight": 112,
          "caption": "Viatris OUS Logo (PRNewsfoto/Viatris Inc.)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q8X7v9Q2NGJ8HikeN5BEPA--~B/aD0xMTI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b.cf.webp",
              "width": 400,
              "height": 112,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g4h5fNpHKz3PzdbDqFxRYg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viatris-recognized-one-fortune-worlds-130000796.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viatris-recognized-one-fortune-worlds-130000796.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T03:36:19+00:00",
    "headline": "Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)",
    "summary": "Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers.",
    "url": "https://finance.yahoo.com/news/reflecting-generic-pharmaceuticals-stocks-q3-033619510.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "691372f6-b5ec-33f7-897a-c697b5e7ac14",
      "content": {
        "id": "691372f6-b5ec-33f7-897a-c697b5e7ac14",
        "contentType": "STORY",
        "title": "Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)",
        "description": "",
        "summary": "Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers.",
        "pubDate": "2025-11-13T03:36:19Z",
        "displayTime": "2025-11-13T03:36:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "VTRS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZ5PSZg5aKFn_8IHve8fGQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4bPZw8EZ18ugKQPfipbnLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reflecting-generic-pharmaceuticals-stocks-q3-033619510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reflecting-generic-pharmaceuticals-stocks-q3-033619510.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T19:10:01+00:00",
    "headline": "How Recent Developments Are Rewriting the Story for Viatris",
    "summary": "Viatris has seen its Fair Value Estimate nudge higher from $12.00 to $12.13 as analysts revise their assumptions for the company's future growth and market opportunities. This modest upward adjustment reflects improved revenue expectations and reduced business risk, along with growing optimism about Viatris's ability to execute on its initiatives. Stay tuned to discover how ongoing shifts in analyst sentiment may impact your understanding of Viatris’s evolving narrative in the months...",
    "url": "https://finance.yahoo.com/news/recent-developments-rewriting-story-viatris-191001754.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2d839bdd-bc49-33dc-9ac2-a7241c9ad99b",
      "content": {
        "id": "2d839bdd-bc49-33dc-9ac2-a7241c9ad99b",
        "contentType": "STORY",
        "title": "How Recent Developments Are Rewriting the Story for Viatris",
        "description": "",
        "summary": "Viatris has seen its Fair Value Estimate nudge higher from $12.00 to $12.13 as analysts revise their assumptions for the company's future growth and market opportunities. This modest upward adjustment reflects improved revenue expectations and reduced business risk, along with growing optimism about Viatris's ability to execute on its initiatives. Stay tuned to discover how ongoing shifts in analyst sentiment may impact your understanding of Viatris’s evolving narrative in the months...",
        "pubDate": "2025-11-13T19:10:01Z",
        "displayTime": "2025-11-13T19:10:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pVOKMAerbRsXv56pHka6Lw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmyGBi4taxQExvvwka_9KQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-rewriting-story-viatris-191001754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recent-developments-rewriting-story-viatris-191001754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]